BioVie Inc. (BIVI)
Nasdaq: BIVI · Pharmaceutical Preparations · Carson City, NV · filing with the SEC since 2013
Who owns BioVie Inc.
As filed with the SECHolders of 5% or more
5
Acuitas Group Holdings, LLC holds 15.8% of Class A Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Jun 30, 2025 says.
Directors and officers
8
report now, of 21 people on the record since 2016. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Acuitas Group Holdings, LLC
SCHEDULE 13D/A · filed Jun 30, 2025 · Class A Common Stock, par value $0.0001 per share
Morgan Stanley
SCHEDULE 13G/A · filed Aug 7, 2026 · Class A Common Stock · 8% in Aug 7, 2026
Alta Partners LLC
SCHEDULE 13G · filed Aug 19, 2026 · Class A Common Stock
Jane Street Group, LLC
SCHEDULE 13G · filed Sep 3, 2026 · Class A Common Stock, $0.0001 par value per share
Do Cuong V
SCHEDULE 13D · filed Mar 25, 2026 · Class A Common Stock, par value $0.0001 per share
3i, LP
SCHEDULE 13G/A · filed Feb 11, 2025 · Class A Common Stock, $0.0001 par value per share · reported falling below 5%
What BIVI reports owning in othersstakes of 5% or more, and other ties
BioVie Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
4purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 21 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Do Cuong V | President & CEO | 0 | $0 | 0 | 1 | $0 |
| Kim Joanne Wendy | Chief Financial Officer | 0 | $0 | 0 | 1 | $0 |
| Palumbo Joseph M | Chief Medical Officer | 0 | $0 | 0 | 1 | $0 |
| Chappell Amy Suzon | director | 0 | $0 | 0 | 1 | $0 |